PTGX vs XLV
Protagonist Therapeutics Inc (PTGX) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
XLV does not have a complete income-statement cache yet.
PTGX currently screens at market cap $7.25B. XLV currently screens at market cap $0.
Not investment advice. Open the PTGX and XLV stock pages for the full models.
Not investment advice.